BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Treatment
9 results:

  • 1. Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study.
    Luo L; Lin L; Zhang X; Cai Q; Zhao H; Xu C; Cong Q
    Biomed Res Int; 2020; 2020():1314967. PubMed ID: 31998776
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patterns of care and survival outcomes in patients with astroblastoma: an individual patient data analysis of 152 cases.
    Mallick S; Benson R; Venkatesulu B; Melgandi W; Rath GK
    Childs Nerv Syst; 2017 Aug; 33(8):1295-1302. PubMed ID: 28477040
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The toxicity of nitrofuran compounds on melanoma and neuroblastoma cells is enhanced by Olaparib and ameliorated by melanin pigment.
    McNeil EM; Ritchie AM; Melton DW
    DNA Repair (Amst); 2013 Nov; 12(11):1000-6. PubMed ID: 24070777
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. xpf protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
    Hatch SB; Swift LP; Caporali S; Carter R; Hill EJ; MacGregor TP; D'Atri S; Middleton MR; McHugh PJ; Sharma RA
    Int J Cancer; 2014 Mar; 134(6):1495-503. PubMed ID: 23982883
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
    Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
    Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
    Li W; Melton DW
    Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of stage I testicular seminoma over a period of 49 years.
    Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
    Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours.
    Köberle B; Masters JR; Hartley JA; Wood RD
    Curr Biol; 1999 Mar; 9(5):273-6. PubMed ID: 10074455
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.